by Andreu Prados
A recent randomized has found that prebiotic supplementation may influence appetite control and energy intake in children with overweight and obesity.
by Paul Enck
A recent study, led by Dr. Paul Wilmes from the Luxembourg Centre for Systems Biomedicine at the University of Luxembourg (Luxembourg), adds new insights about the human microbiome in type 1 diabetes mellitus (T1DM) from an integrated multi-omics analysis.
by Heather Galipeau
The Gairdner Foundation and the Farncombe Institute at McMaster University (Canada) held a joint symposium, “The Intestinal Microbiome: Beyond Associations and into the Clinic”.
by Andreu Prados
A recent cross-sectional study, led by Prof. Tim Spector and Dr. Jordana Bell from the Department of Twin Research & Genetic Epidemiology at King’s College London (United Kingdom), has found that the human faecal microbiome is related to abdominal adiposity.
by Andreu Prados
A recent study has found that vitamin D deficiency is involved in metabolic syndrome progression through intestinal integrity disruption and gut microbiota dysbiosis in mice.
by Kristina Campbell
Individuals may experience recurrent weight gain and re-emergence of metabolic complications, a phenomenon sometimes called the "yo-yo effect". But growing evidence of the role of gut microbiota in obesity and metabolic health may bring the potential to address this problem in new ways.
by Andreu Prados
The MoBioFood (Molecular Bioactivity of Foods) Research Group from the Biochemistry and Biotechnology Department at the Rovira i Virgili University in Tarragona (Spain) focuses on the interaction of flavonoids with the enteroendocrine system, and the role of these compounds in maintaining intestinal barrier integrity and/or inducing anti-inflammatory effects in the gastrointestinal tract.
by Andreu Prados
A recent study, led by Dr. Jonathan Cedernaes from the Department of Neuroscience at Uppsala University (Sweden), has found that short-term sleep loss may induce subtle changes in the human gut microbiota.
by Kristina Campbell
Previous studies have identified Akkermansia muciniphila as an important bacterium in metabolic health—able to prevent the development of obesity in animal models. Until now, however, its mechanisms were unclear and its effects had never been tested in humans.
Leading researchers in the field of gut microbiota and metabolic health are set to discuss new insights at an upcoming symposium in Denmark, organized by The Gut, Grain and Greens (3G) Center and the Danish Diabetes Academy.
